Sutro Biopharma to present at World ADC Conference

• Sutro Biopharma will attend the 17th Annual World ADC Conference in San Diego, October 12-15, 2026.
• A plenary talk on early clinical safety and pharmacokinetics for lead ADC candidate STRO-004 is scheduled for October 13.
• Additional sessions will cover preclinical updates on STRO-006, dual-payload ADC research, and STRO-227 on October 12-14.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sutro Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610120800PRIMZONEFULLFEED9843504) on October 12, 2026, and is solely responsible for the information contained therein.